NICOLAU YVES CLAUDE has a total of 11 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CENTROSE LLC, KEYBIOSCIENCE AG and JIANGYIN USUN PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Special acyclic compounds | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Nicolau Yves Claude | 11 |
#2 | Greferath Ruth | 8 |
#3 | Lehn Jean-Marie | 7 |
#4 | Fylaktakidou Konstantina C | 3 |
#5 | Hickman David | 2 |
#6 | Tosi Pierre-Francois | 2 |
#7 | Kieda Claudine | 1 |
#8 | Fylaktakidou Konstantina | 1 |
#9 | Flyaktakidou Konstantina C | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015138916A1 | Myo-inositol trispyrophoshate as an anti-diabetic agent | |
US2010029593A1 | Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin | |
US2010029594A1 | Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin | |
US2006073158A1 | Methods and compositions comprising supramolecular constructs | |
WO9410198A1 | Method of reducing multidrug resistance in cells and tissues |